|
Genentech has arranged a conference call Thursday June 2nd to discuss the results of the NSABP-B-31 and NCCTG-N9831 Herceptin Trials and the ECOG 2100 Avastin Herceptin Trial. Unfortunately participation on this call is limited to invited guests only.
We will not be discussing results of the HERA Trial as they were sponsored by Roche.
Please reply with one specific question that you would like to ask. We will email them to Genentech beforehand and hopefully they will be covered.
Please answer by May 31
Regards
Joe
|